UK markets closed

Accelerate Diagnostics, Inc. (AXDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.9248+0.0049 (+0.53%)
At close: 04:00PM EDT
0.9310 +0.01 (+0.67%)
After hours: 07:04PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 20.04M
Enterprise value 46.04M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.96
Price/book (mrq)N/A
Enterprise value/revenue 3.82
Enterprise value/EBITDA -0.92

Trading information

Stock price history

Beta (5Y monthly) 0.53
52-week change 3-88.10%
S&P500 52-week change 322.38%
52-week high 311.9000
52-week low 30.7300
50-day moving average 30.9500
200-day moving average 33.9604

Share statistics

Avg vol (3-month) 367.07k
Avg vol (10-day) 330.07k
Shares outstanding 521.66M
Implied shares outstanding 622.07M
Float 813.46M
% held by insiders 137.11%
% held by institutions 112.85%
Shares short (15 Apr 2024) 4373.71k
Short ratio (15 Apr 2024) 44.71
Short % of float (15 Apr 2024) 42.77%
Short % of shares outstanding (15 Apr 2024) 41.73%
Shares short (prior month 15 Mar 2024) 4287.62k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 312 Jul 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-354.48%

Management effectiveness

Return on assets (ttm)-70.07%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)12.06M
Revenue per share (ttm)0.97
Quarterly revenue growth (yoy)1.90%
Gross profit (ttm)N/A
EBITDA -50.77M
Net income avi to common (ttm)-61.62M
Diluted EPS (ttm)-4.9400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.22M
Total cash per share (mrq)0.61
Total debt (mrq)39.22M
Total debt/equity (mrq)N/A
Current ratio (mrq)2.03
Book value per share (mrq)-1.37

Cash flow statement

Operating cash flow (ttm)-40.2M
Levered free cash flow (ttm)-25.94M